Table 7.
Vaccines under the clinical trials.
S. no. | Vaccine | Clinical trials |
---|---|---|
1. | LV-SMENP-DC vaccine and antigen-specific CTLs | Phase 1/Phase 2 (NCT04276896) |
2. | Pathogen-specific artificial antigen presenting cells (aAPC) | Phase 1 (NCT04299724) |
3. | mRNA-1273 vaccine | Phase 1 (NCT04283461) |
4. | ChAdOx1 nCoV-19 vaccine | Phase 1/Phase 2 (NCT04324606) |
5. | Recombinant novel CoV vaccine (adenovirus type 5 vector) | Phase 1 (NCT04313127) |
6. | Bacillus Calmette–Guérin (BCG) vaccine | Phase 1 (EudraCT: 2020-000919-69) |